| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0089 | 0.9 |